新光药业股东和丰投资拟合计减持不超3%股份

Core Viewpoint - The company Shengkang Pharmaceutical (300519.SZ) announced that its shareholder, Shengzhou Hefeng Investment Co., Ltd. (referred to as "Hefeng Investment"), plans to reduce its holdings by up to 4.8 million shares, which represents no more than 3% of the company's total share capital, within three months after 15 trading days from the announcement date [1] Summary by Category - Shareholder Actions - Hefeng Investment intends to reduce its stake in the company through centralized bidding or block trading methods [1]